PT94030A - Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella - Google Patents

Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella

Info

Publication number
PT94030A
PT94030A PT94030A PT9403090A PT94030A PT 94030 A PT94030 A PT 94030A PT 94030 A PT94030 A PT 94030A PT 9403090 A PT9403090 A PT 9403090A PT 94030 A PT94030 A PT 94030A
Authority
PT
Portugal
Prior art keywords
preparation
toxic effects
protective against
against bordetella
antigen protective
Prior art date
Application number
PT94030A
Other languages
English (en)
Other versions
PT94030B (pt
Inventor
Nicole Guiso-Maclouf
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PT94030A publication Critical patent/PT94030A/pt
Publication of PT94030B publication Critical patent/PT94030B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT94030A 1989-05-12 1990-05-14 Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella PT94030B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906321A FR2646776B1 (fr) 1989-05-12 1989-05-12 Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella

Publications (2)

Publication Number Publication Date
PT94030A true PT94030A (pt) 1991-01-08
PT94030B PT94030B (pt) 1997-07-31

Family

ID=9381646

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94030A PT94030B (pt) 1989-05-12 1990-05-14 Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella

Country Status (10)

Country Link
US (3) US6214356B1 (pt)
EP (1) EP0424518B1 (pt)
JP (1) JP3399525B2 (pt)
AT (1) ATE115861T1 (pt)
CA (1) CA2033085C (pt)
DE (1) DE69015314T2 (pt)
ES (1) ES2066206T3 (pt)
FR (1) FR2646776B1 (pt)
PT (1) PT94030B (pt)
WO (1) WO1990013312A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (fr) 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis
EP1667712B1 (en) 2003-10-02 2010-07-21 GlaxoSmithKline Biologicals S.A. B. pertussis antigens and use thereof in vaccination
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
US4652521A (en) * 1985-03-04 1987-03-24 Regents Of The University Of Minnesota Method for the early diagnosis of bordetella diseases and kit therefor
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
EP0267998A1 (en) * 1986-11-17 1988-05-25 Institut Pasteur Means for protecting against bordetella infections and toxic processes
FR2606789B1 (fr) * 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
FR2621597B1 (fr) 1987-07-24 1992-07-31 Pasteur Institut Procede de clonage et d'expression de genes codant pour des proteines constituant des edifices fonctionnels organises
EP0338169B1 (en) * 1988-04-19 1996-07-24 Institut Pasteur Method for obtaining protective antigens against bordetella infections and toxic processes
EP0338170A1 (en) * 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
ATE121754T1 (de) * 1989-09-04 1995-05-15 Wellcome Found Vakzine gegen bordetella.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
JPH08500734A (ja) * 1992-08-18 1996-01-30 デュファル インターナショナル リサーチ ベスローテン フェンノートシャップ 気管支敗血症菌（Ｂｏｒｄｅｔｅｌｌａ ｂｒｏｎｃｈｉｓｅｐｔｉｃａ）ワクチン
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
ATE496634T1 (de) * 1995-05-04 2011-02-15 Sanofi Pasteur Ltd Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
DK1284993T3 (da) * 2000-05-25 2008-07-28 Pasteur Institut Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater
ES2331348T3 (es) 2000-09-15 2009-12-30 Pasteur Institut Vectores proteinicos para el suministro de moleculas a las celulas que expresan cd11b.

Also Published As

Publication number Publication date
JP3399525B2 (ja) 2003-04-21
CA2033085C (fr) 2003-07-22
ATE115861T1 (de) 1995-01-15
FR2646776A1 (fr) 1990-11-16
EP0424518A1 (fr) 1991-05-02
DE69015314D1 (de) 1995-02-02
US20030224003A1 (en) 2003-12-04
FR2646776B1 (fr) 1994-06-03
CA2033085A1 (fr) 1990-11-13
ES2066206T3 (es) 1995-03-01
WO1990013312A1 (fr) 1990-11-15
DE69015314T2 (de) 1996-11-28
US7211263B2 (en) 2007-05-01
EP0424518B1 (fr) 1994-12-21
US20020172691A1 (en) 2002-11-21
JPH03506044A (ja) 1991-12-26
PT94030B (pt) 1997-07-31
US6214356B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
DK0754055T3 (da) Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder
PL304419A1 (en) Urease based vaccine against heliobacter infections
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
EP0835315A4 (en) VACCINE AGAINST THE VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTION DISEASES IN PIGS
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
RU94045898A (ru) Вакцинная композиция, способ стимулирования иммунной системы
DE68924162D1 (de) Stressproteine und verwendungen dafür.
DE69331758D1 (de) Fibrinogen-bildungsprotein
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
US4079126A (en) Method of preparing a component consisting of sugar, lipid and protein derived from Pseudomonas aeruginosa which possess anti-tumor and interferon inducing properties
PT94030A (pt) Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella
EP0830456A4 (en) INSULATED FrpB NUCLEIC ACID MOLECULE AND CORRESPONDING VACCINE
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
WO2002092131A3 (en) Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
EP0161095A3 (en) Vaccine against urinary infection
PT99923A (pt) Processo para a preparacao de proteinas hibridas de plasmodium falciparum que contem sequencias dos antigenios da malaria hrpii e serp e de composicoes farmaceuticas que contem estas proteinas
Panse et al. Passive immunity in experimental cholera
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
DK0835309T3 (da) Vaccine imod infektiøse agenser, præparat til behandling og forebyggelse af HIV infektioner
Puentes et al. Efficacy of Various Non‐Oily Adjuvants in Immunization Against the Aujeszky's Disease (Pseudorabies) Virus
DE60042776D1 (de) Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen
RU2005133709A (ru) Холестеринсодержащие соединения и их применение в качестве иммуногенов против borrelia burgdorferi
WO2003040163B1 (en) Immunomodulating saponins, a method for their preparation and their use for vaccines

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19970506

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120507